The keynote presentation featured Jonathan Cohen and Scott Stephenson discussing speech recognition software in a session moderated by Jeff Herbst.

In this keynote interview, Renee Yao asked Scott Barclay, Fabien Beckers and Chakri Toleti where artificial intelligence applications in healthcare are headed.

Distinct roles for business development and CVC investor professionals was one of the ideas floated at a discussion on innovation plays and CVC's impact.

Clareo’s Paul Donnellan asked Brian Hoff how he set up innovation strategies and an internal incubator at Exelon.

Embracing the innovation ecosystem and ensuring strategic cooperation were identified as key for CVC-startup relations in a session chaired by Saeed Amidi, CEO and founder of Plug and Play.

Touchdown Ventures co-founder Scott Lenet and Accenture Ventures head Mike Redding discussed the relationship between corporate venturing arms and parent organisation.

In-Q-Tel managing partner George Hoyem discussed disinformation campaigns carried out through artificial intelligence and machine learning technologies in recent years with Graphika CEO John Kelly and UC Berkeley professor Hany Farid.

Unlocking innovation potential through corporate venturing and business unit development was the topic for Nicolas Sauvage, Brandon Yahn, Aaron Brandt and Nathan Pascarella.

Nicolas Sauvage discussed TDK’s approach to innovation and why they put CVC into play, with Orrick's Ellen Ehrenpreis asking the questions.

Bill Taranto, who oversees Merck & Co’s Global Health Innovation Fund, talks to GCV’s James Mawson on the strategies of a sustainable CVC program.